{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:45:55Z","timestamp":1795023955450,"version":"4.10.2"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007632","name":"Changhua Christian Hospital","doi-asserted-by":"publisher","award":["109-IRP-CCH-008 and 108-CCHIRP-018"],"award-info":[{"award-number":["109-IRP-CCH-008 and 108-CCHIRP-018"]}],"id":[{"id":"10.13039\/501100007632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background\/purpose<\/jats:title>\n<jats:p>An increased prevalence of non-alcoholic fatty liver disease (NAFLD) is observed in patients with inflammatory bowel disease (IBD) in Western countries. Both intestinal inflammation and metabolic factors contribute to the pathogenesis of IBD-associated NAFLD. The burden of NAFLD is not clear in the Asian population. This study aimed to evaluate the prevalence of NAFLD and liver fibrosis in a cohort of Taiwanese patients with IBD.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>From January to December 2019, patients with IBD who underwent ultrasound examination were enrolled. Hepatic steatosis and fibrosis were measured with liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) using FibroScan. Patients with a history of excessive alcohol or recent steroid use were excluded. Univariate and multivariate analysis were performed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 81 consecutive patients were enrolled and included in the analysis (45 with ulcerative colitis, 36 with Crohn\u2019s disease). The median age was 42 years old. The patients were classified in terms of body mass index as normal weight (54.3%), underweight (11.1%), overweight (28.4%), and obese (6.2%). The mean CAP increased to 162.22 dB\/m in the underweight group, 210.86 dB\/m in the normal weight group, 260.7 dB\/m in the overweight group, and 274.0 dB\/m in the obese group. NAFLD was observed in 29.6% of the patients, 1.2% of which had significant fibrosis. Increased body mass index (odds ratio [OR] 1.33, 95% confidence interval [CI] 1.1\u20131.62) and older age at IBD diagnosis (OR: 1.05, 95% CI 1\u20131.11) was found to be associated with the presence of NAFLD.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>In this study, the prevalence of NAFLD was lower (29.6%) in IBD patients than in the Western population. Higher BMI and older age were associated with NAFLD in our study.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0252286","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T19:26:56Z","timestamp":1622143616000},"page":"e0252286","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3494-2245","authenticated-orcid":true,"given":"Hsu-Heng","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siou-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsui-Chun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Huei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5936-7112","authenticated-orcid":true,"given":"Yang-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"pone.0252286.ref001","doi-asserted-by":"crossref","first-page":"e9537","DOI":"10.7717\/peerj.9537","article-title":"Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis","volume":"8","author":"HH Yen","year":"2020","journal-title":"PeerJ"},{"issue":"1","key":"pone.0252286.ref002","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5217\/ir.2018.00096","article-title":"Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study","volume":"17","author":"HH Yen","year":"2019","journal-title":"Intest Res"},{"issue":"3","key":"pone.0252286.ref003","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5217\/ir.2017.15.3.266","article-title":"Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease","volume":"15","author":"SC Wei","year":"2017","journal-title":"Intest Res"},{"issue":"3","key":"pone.0252286.ref004","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5217\/ir.2017.15.3.285","article-title":"Management of Crohn\u2019s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease","volume":"15","author":"SC Wei","year":"2017","journal-title":"Intest Res"},{"issue":"5","key":"pone.0252286.ref005","first-page":"831","article-title":"Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative\/HBcAb-positive patients receiving rituximab for rheumatoid arthritis","volume":"35","author":"YC Tien","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"pone.0252286.ref006","doi-asserted-by":"crossref","first-page":"e0237582","DOI":"10.1371\/journal.pone.0237582","article-title":"Glecaprevir-pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting","volume":"15","author":"HH Yen","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"pone.0252286.ref007","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis","volume":"4","author":"J Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"pone.0252286.ref008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ibd.21669","article-title":"Barritt ASt. Changing shape of disease: nonalcoholic fatty liver disease in Crohn\u2019s disease-a case series and review of the literature","volume":"18","author":"CE McGowan","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0252286.ref009","article-title":"Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","author":"A Lin","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0252286.ref010","article-title":"Non-alcoholic fatty liver disease in inflammatory bowel disease patients","author":"K Karaivazoglou","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"pone.0252286.ref011","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ibd\/izy200","article-title":"Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography","volume":"25","author":"C Saroli Palumbo","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"pone.0252286.ref012","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/hepr.12828","article-title":"Significance of non-alcoholic fatty liver disease in Crohn\u2019s disease: A retrospective cohort study","volume":"47","author":"S Sagami","year":"2017","journal-title":"Hepatol Res"},{"issue":"8","key":"pone.0252286.ref013","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/MEG.0000000000001319","article-title":"Hepatic steatosis and patients with inflammatory bowel disease: when transient elastography makes the difference","volume":"31","author":"C Arieira","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"pone.0252286.ref014","article-title":"Noninvasive and Convenient Screening of Metabolic Syndrome Using the Controlled Attenuation Parameter Technology: An Evaluation Based on Self-Paid Health Examination Participants","volume":"8","author":"YJ Lin","year":"2019","journal-title":"J Clin Med"},{"issue":"10","key":"pone.0252286.ref015","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.transproceed.2018.06.039","article-title":"Predicting Hepatic Steatosis in Living Liver Donors Via Controlled Attenuation Parameter","volume":"50","author":"YH Yen","year":"2018","journal-title":"Transplant Proc"},{"issue":"4","key":"pone.0252286.ref016","doi-asserted-by":"crossref","first-page":"e0176027","DOI":"10.1371\/journal.pone.0176027","article-title":"Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study","volume":"12","author":"YH Yen","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"pone.0252286.ref017","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"T Karlas","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"pone.0252286.ref018","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"VW Wong","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"pone.0252286.ref019","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"S Dasarathy","year":"2009","journal-title":"J Hepatol"},{"issue":"11","key":"pone.0252286.ref020","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/ibd\/izz043","article-title":"Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease","volume":"25","author":"ZY Zou","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0252286.ref021","article-title":"Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare","author":"G Ritaccio","year":"2020","journal-title":"Dig Dis Sci"},{"key":"pone.0252286.ref022","article-title":"Sarcopenia is a new risk factor of non-alcoholic fatty liver disease in patients with inflammatory bowel disease","author":"MK Kang","year":"2020","journal-title":"Dig Dis"},{"key":"pone.0252286.ref023","doi-asserted-by":"crossref","first-page":"e10944","DOI":"10.7717\/peerj.10944","article-title":"Direct-acting antiviral treatment for Hepatitis C Virus in geriatric patients: a real-world retrospective comparison between early and late elderly patients","volume":"9","author":"H SP Yen","year":"2021","journal-title":"PeerJ"},{"issue":"1","key":"pone.0252286.ref024","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12876-021-01792-8","article-title":"Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study","volume":"21","author":"HH Yen","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"pone.0252286.ref025","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis","volume":"70","author":"F Zhou","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"pone.0252286.ref026","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"N Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"pone.0252286.ref027","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"ZM Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"pone.0252286.ref028","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2459\/JCM.0000000000000149","article-title":"Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage?","volume":"16","author":"MM Ciccone","year":"2015","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"1","key":"pone.0252286.ref029","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12967-019-02164-3","article-title":"Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study","volume":"17","author":"WC Lin","year":"2019","journal-title":"J Transl Med"},{"issue":"34","key":"pone.0252286.ref030","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.3748\/wjg.v22.i34.7727","article-title":"Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article","volume":"22","author":"CY Chao","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"2","key":"pone.0252286.ref031","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/jgh.12053","article-title":"Genetics of inflammatory bowel diseases: a comparison between Western and Eastern perspectives","volume":"28","author":"JH Cheon","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"pone.0252286.ref032","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jgh.14872","article-title":"The epidemiology of inflammatory bowel disease: East meets west","volume":"35","author":"WY Mak","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"pone.0252286.ref033","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"C Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"issue":"11","key":"pone.0252286.ref034","doi-asserted-by":"crossref","first-page":"e0206450","DOI":"10.1371\/journal.pone.0206450","article-title":"Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study","volume":"13","author":"LC Adams","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"pone.0252286.ref035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4254\/wjh.v12.i9.661","article-title":"Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?","volume":"12","author":"VB Amorim","year":"2020","journal-title":"World J Hepatol"},{"issue":"5","key":"pone.0252286.ref036","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/00365521.2011.647412","article-title":"Evaluation of liver fibrosis by transient elastography (Fibroscan(R)) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial","volume":"47","author":"A Barbero-Villares","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"pone.0252286.ref037","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.11.052","article-title":"Use of Cross-Sectional Imaging for Tight Monitoring of Inflammatory Bowel Diseases","volume":"18","author":"M Allocca","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"pone.0252286.ref038","doi-asserted-by":"crossref","first-page":"e25090","DOI":"10.1097\/MD.0000000000025090","article-title":"Clinical features and treatment of inflammatory bowel disease in a low-incidence area: A hospital-based retrospective cohort study in Taiwan","volume":"100","author":"HH Yen","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"pone.0252286.ref039","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.15673","article-title":"Modelling NAFLD disease burden in four Asian regions-2019-2030","volume":"51","author":"C Estes","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"pone.0252286.ref040","doi-asserted-by":"crossref","first-page":"e0139796","DOI":"10.1371\/journal.pone.0139796","article-title":"Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients","volume":"10","author":"JF Huang","year":"2015","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T19:27:36Z","timestamp":1622143656000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252286"}},"subtitle":[],"editor":[{"given":"Wan-Long","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0252286","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0252286.g001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0252286.g002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0252286.t001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0252286.t002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0252286.t003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0252286.s001","asserted-by":"subject"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]}}}